ACNP Task Force report on SSRIs and suicidal behavior in youth.
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
Mann
J John
JJ
Columbia University/New York State Psychiatric Institute, New York, NY 10032, USA. jjm@columbia.edu
Emslie
Graham
G
Baldessarini
Ross J
RJ
Beardslee
William
W
Fawcett
Jan A
JA
Goodwin
Frederick K
FK
Leon
Andrew C
AC
Meltzer
Herbert Y
HY
Ryan
Neal D
ND
Shaffer
David
D
Wagner
Karen D
KD
D000293:Adolescent; D000328:Adult; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013405:Suicide / Q000523:psychology* / Q000706:statistics & numerical data; D013406:Suicide, Attempted / Q000523:psychology; D014481:United States / Q000453:epidemiology
D017367:Selective Serotonin Reuptake Inhibitors